Author(s): Abhishek Mangaonkar, Terra Lasho, Christy Finke, et al. Abstract: PF501 Session topic: 10. Myelodysplastic syndromes – Clinical Background: The 2016 iteration of World Health Organization (WHO) classification of myeloid neoplasms removed the sub-category of “refractory cytopenia with multilineage dysplasia” and reclassified patients with myelodysplastic syndromes (MDS) and multilineage dysplasia (MLD) into...
Pro zobrazení tohoto obsahu je třeba být přihlášen.